Zerga, M. (2026) “New therapeutic options for relapsed/refractory diffuse large b-cell lymphoma. Treatment with tafasitamab + lenalidomide”, Journal of Hematology, 29(3), pp. 61–70. doi: 10.48057/hematologa.v29i3.687.